Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.49 |
| ▸ | CA2 | P00918 | 4/20 | 0.49 |
| ▸ | CA4 | P22748 | 4/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.49 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA3 | P07451 | 3/20 | 0.43 |
| ▸ | CA6 | P23280 | 3/20 | 0.43 |
| ▸ | CA5A | P35218 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9426960 | 1.00 | CA1 (0.49) | CA1CA2CA4NFKB1ESR1 | |
| SCHEMBL3397197 | 0.85 | NFKB1 (0.61) | CA1CA2CA4NFKB1ESR1 | |
| SCHEMBL16267724 | 0.83 | CA1 (0.46) | CA1CA2CA4NFKB1ESR1 | |
| SCHEMBL6567044 | 0.79 | CA1 (0.49) | CA1CA2CA4NFKB1ESR1 | |
| SCHEMBL6567050 | 0.79 | CA1 (0.49) | CA1CA2CA4NFKB1ESR1 | |
| SCHEMBL27427808 | 0.79 | ESR1 (0.55) | CA1CA2ESR1KDM4ECA12 | |
| SCHEMBL16150378 | 0.76 | CA1 (0.42) | CA1CA2CA4NFKB1ESR1 | |
| SCHEMBL1552308 | 0.76 | ERN1 (0.40) | CA1CA2KDM4EHSD17B10KMT2A | |
| Acrylic Acid SCHEMBL27883843 | 0.76 | LMNA (0.42) | CA1CA2CA4NFKB1MIF | |
| SCHEMBL16048950 | 0.74 | CA1 (0.55) | CA1CA2CA4NFKB1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109608799-A | A kind of stretch-proof sealing element for offshore oil | 铜陵新创流体科技有限公司 | 2019-04-12 | — | — | CN | claimed |
| CN-107057206-A | A kind of high-temp.-resistant electric cable for computer material | 安徽三鑫电缆材料有限公司 | 2017-08-18 | — | — | CN | claimed |
| CN-106957474-A | A kind of polyethylene insulation computer cable material | 安徽三鑫电缆材料有限公司 | 2017-07-18 | — | — | CN | claimed |
| US-9340477-B2 | Process for production of hydroxystilbene derivative having physiological activity | UHA MIKAKUTO CO., LTD. (JP) | 2016-05-17 | — | — | US | claimed |
| EP-2763756-A1 | BROMOFLUOROCARBON COMPOSITIONS | American Pacific Corporation (US) | 2014-08-13 | — | — | EP | claimed |
| US-20130310611-A1 | PROCESS FOR PRODUCTION OF PHENOLIC POLYMERIZABLE COMPOUND HAVING PHYSIOLOGICAL ACTIVITY | UHA MIKAKUTO CO., LTD. (JP) | 2013-11-21 | — | — | US | claimed |
| US-20130296613-A1 | PROCESS FOR PRODUCTION OF HYDROXYSTILBENE DERIVATIVE HAVING PHYSIOLOGICAL ACTIVITY | UHA MIKAKUTO CO., LTD. (JP) | 2013-11-07 | — | — | US | claimed |
| WO-2013052850-A1 | BROMOFLUOROCARBON COMPOSITIONS | AMERICAN PACIFIC CORPORATION (US) | 2013-04-11 | — | — | WO | claimed |
| CN-1034931-A | Stablizer by coating makes polyolefine in in-reactor stabilization | SHELL OIL CO (US) | 1989-08-23 | — | — | CN | claimed |
| EP-4326203-A1 | FIBROUS LAYER WITH HOTMELT COATING COMPOSITION | The Procter & Gamble Company (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4326204-A1 | HYDROPHILIC HOTMELT ADHESIVE | The Procter & Gamble Company (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4326202-A1 | LAMINATE FOR USE IN AN ABSORBENT ARTICLE | The Procter & Gamble Company (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2024012575-A1 | REVERSIBLE CROSSLINKED FOAM ARTICLE AND PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-01-18 | — | — | WO | disclosed |
| CN-115969774-A | Gel system containing ionic liquid and application thereof | 中国药科大学 | 2023-04-18 | — | — | CN | disclosed |
| WO-2003085018-A1 | PRODUCTION OF POLYOXYMETHYLENE AND SUITABLE CATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-16 | — | — | WO | disclosed |
| EP-1200367-A1 | RADIATION-CURABLE COMPOSITION WITH SIMULTANEOUS COLOR FORMATION DURING CURE | DSM N.V. (NL) | 2002-05-02 | — | — | EP | disclosed |
| EP-1189848-A1 | LIQUID CURABLE RESIN COMPOSITION AND CURED PRODUCTS | DSM N.V. (NL) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001009053-A1 | RADIATION-CURABLE COMPOSITION WITH SIMULTANEOUS COLOR FORMATION DURING CURE | DSM N.V. (NL) | 2001-02-08 | — | — | WO | disclosed |
| WO-2000064831-A1 | LIQUID CURABLE RESIN COMPOSITION AND CURED PRODUCTS | DSM N.V. (NL) | 2000-11-02 | — | — | WO | disclosed |
| US-5294643-A | Cinnamamide derivative | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI (JP) | 1994-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296613-A1 | PROCESS FOR PRODUCTION OF HYDROXYSTILBENE DERIVATIVE HAVING PHYSIOLOGICAL ACTIVITY | HSD11B1, CYP8B1, HSD11B2 | CA1 257/4885CA2 72/4885CA4 105/4885 |
| US-20130310611-A1 | PROCESS FOR PRODUCTION OF PHENOLIC POLYMERIZABLE COMPOUND HAVING PHYSIOLOGICAL ACTIVITY | HPD, PAH, HAO2 | CA1 535/4885CA2 47/4885CA4 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.